We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LAD:NYSELithia Motors, Inc. Analysis

Data as of 2026-04-14 - not real-time

$279.06

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Lithia Motors (LAD) is trading at $279.06, just below its 50‑day SMA of $278.88 and near the $280.28 resistance level, with a 14‑day RSI of 64 indicating modest overbought pressure. The MACD histogram is positive (+4.86) and the signal is bullish, yet volume is on a decreasing trend and the 30‑day volatility is elevated at 28%, supporting a short‑term bearish bias. Fundamentally, the stock sports a low trailing PE of 8.6, a price‑to‑book near parity (0.99), and a price‑to‑sales of 0.17, suggesting it is undervalued relative to peers. The dividend yield of 0.81% is backed by a very low payout ratio of 6.7%, making the payout appear sustainable despite a high debt‑to‑equity ratio.
Recent acquisitions of Toyota of Gallatin and Mercedes‑Benz of Medford have added $225 million in annualized U.S. revenue, reinforcing the company's growth narrative. The buy rating from 15 analysts (median target $376) and bullish commentary from billionaire David Abrams add credibility to the upside potential of roughly 33%. While the consumer‑cyclical sector remains sensitive to economic cycles, LAD’s diversified financing operations and strong free cash flow provide a cushion. Overall, the blend of attractive valuation, strategic acquisitions, and dividend safety points to a buy stance for medium‑ to long‑term horizons, with a cautious hold in the immediate term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price flirting with resistance and overbought RSI
  • Decreasing volume and high short‑term volatility
  • Bearish trend direction despite bullish MACD signal

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued valuation multiples (PE, P/B, P/S)
  • Acquisition‑driven revenue boost and strong analyst targets
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Strategic expansion and diversified financing operations
  • Long‑term upside potential of >30% to consensus price target
  • Resilient cash flow generation despite high leverage

Key Metrics & Analysis

Financial Health

Revenue Growth0.30%
Profit Margin2.18%
P/E Ratio8.6
ROE12.42%
ROA4.22%
Debt/Equity235.16
P/B Ratio1.0
Op. Cash Flow$356.7M
Free Cash Flow$774.4M

Technical Analysis

TrendBearish
RSI64.0
Support$239.78
Resistance$280.28
MA 20$255.50
MA 50$278.88
MA 200$310.97
MACDBullish
VolumeDecreasing
Fear & Greed Index87.29

Valuation

Target Price$370.73
Upside/Downside32.85%
GradeUndervalued
TypeValue
Dividend Yield0.81%

Risk Assessment

Beta1.09
Volatility28.21%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.